How to measure insulin clearance
1994; Wiley; Volume: 10; Issue: 2 Linguagem: Inglês
10.1002/dmr.5610100205
ISSN1099-0895
AutoresManuel J. Castillo, André Scheen, Michel Letiexhe, Pierre J. Lefèbvre,
Tópico(s)Diabetes, Cardiovascular Risks, and Lipoproteins
ResumoDiabetes/Metabolism ReviewsVolume 10, Issue 2 p. 119-150 Paper How to measure insulin clearance Manuel J. Castillo, Manuel J. Castillo Department of Physiology, School of Medicine, University of Granada, Granada, Spain Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorAndré J. Scheen, André J. Scheen Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorMichel R. Letiexhe, Michel R. Letiexhe Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorProfessor Pierre J. Lefèbvre, Corresponding Author Professor Pierre J. Lefèbvre Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumDivision of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman (B35), B-4000 Liège 1, BelgiumSearch for more papers by this author Manuel J. Castillo, Manuel J. Castillo Department of Physiology, School of Medicine, University of Granada, Granada, Spain Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorAndré J. Scheen, André J. Scheen Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorMichel R. Letiexhe, Michel R. Letiexhe Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumSearch for more papers by this authorProfessor Pierre J. Lefèbvre, Corresponding Author Professor Pierre J. Lefèbvre Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, University of Liège, Liège, BelgiumDivision of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman (B35), B-4000 Liège 1, BelgiumSearch for more papers by this author First published: July 1994 https://doi.org/10.1002/dmr.5610100205Citations: 50AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ferrannini E, and Cobelli C: The kinetics of insulin in man. I. General aspects. Diabetes/Metab Rev 3: 335–363, 1987. 10.1002/dmr.5610030201 CASPubMedGoogle Scholar 2 Rubenstein AH, Clark JL, Melani F, and Steiner DF: Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature (London) 224: 697–699, 1969. 10.1038/224697a0 CASWeb of Science®Google Scholar 3 Rubenstein AH, Pottenger LA, Mako M, Getz GS, and Steiner DF: The metabolism of proinsulin and insulin by the liver. J Clin Invest 51: 912–921, 1971. 10.1172/JCI106886 PubMedWeb of Science®Google Scholar 4 Silvers A, Swenson RS, Farquhar JW, and Reaven GM: Derivation of a three compartment model describing disappearance of plasma insulin-131I in man. J Clin Invest 48: 1461–1469, 1969. 10.1172/JCI106112 CASPubMedWeb of Science®Google Scholar 5 Turnheim K, and Waldhäusl WK: Essentials of insulin pharmacokinetics. Wien Klin Wochenschr 100: 65–72, 1988. CASPubMedWeb of Science®Google Scholar 6 Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, and Andres R: A model of the kinetics of insulin in man. J. Clin Invest 53: 1481–1492, 1974. 10.1172/JCI107697 CASPubMedWeb of Science®Google Scholar 7 Duckworth WC, and Kitabchi AE: Insulin metabolism and degradation. Endocrine Rev 2: 210–233, 1981. 10.1210/edrv-2-2-210 CASPubMedWeb of Science®Google Scholar 8 Rabkin R, Ryan MP, and Duckworth WC: The renal metabolism of insulin. Diabetologia 27: 351–357, 1984. 10.1007/BF00304849 CASPubMedWeb of Science®Google Scholar 9 Sonne O: Receptor mediated endocytosis and degradation of insulin. Physiol Rev 68: 1129–1196, 1988. 10.1152/physrev.1988.68.4.1129 CASPubMedWeb of Science®Google Scholar 10 Duckworth WC: Insulin degradation: mechanisms, products, and significance. Endocrine Rev 9: 319–345, 1988. 10.1210/edrv-9-3-319 CASPubMedWeb of Science®Google Scholar 11 Hamel FG, Posner BI, Bergeron JJM, Frank BH, and Duckworth WC: Isolation of insulin degradation products from endosomes derived from intact rat liver. J Biol Chem 263: 6703–6708, 1988. CASPubMedWeb of Science®Google Scholar 12 Bergeron JJM, Cruz J, Khan MN, and Posner BI: Uptake of insulin and other ligands into receptor-rich endocytic components of target cells: the endosomal apparatus. Annu Rev Physiol 47: 383–403, 1985. 10.1146/annurev.ph.47.030185.002123 CASPubMedWeb of Science®Google Scholar 13 Levy JR, and Olefsky JM: Retroendocytosis of insulin in rat adipocytes. Endocrinology 119: 572–579, 1986. 10.1210/endo-119-2-572 CASPubMedWeb of Science®Google Scholar 14 Brandenburg D, Diaconescu C, Klotz G, Macke P, Neffe J, Saunders D, and Schuttler A: Biological action and fate of photo-affinity-labelled insulin receptor complexes. Biochimie 67: 1111–1117, 1985. 10.1016/S0300-9084(85)80108-5 CASPubMedWeb of Science®Google Scholar 15 Schuttler A, Diaconescu C, Saunders DG, and Brandenburg D: Time dependence of biological activity induced by covalent insulin-receptor complexes in rat adipocytes. Biochem J 232: 49–53, 1985. CASPubMedWeb of Science®Google Scholar 16 Carpentier J-L: The cell biology of the insulin receptor. Diabetologia 32: 627–635, 1989. 10.1007/BF00274248 CASPubMedWeb of Science®Google Scholar 17 Navalesi R, Pilo A, and Ferrannini E: Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. J. Clin Invest 61: 197–208, 1978. 10.1172/JCI108918 CASPubMedWeb of Science®Google Scholar 18 Tranberg K: Hepatic uptake of insulin in man. Am J Physiol 237: E509–E518, 1979. 10.1152/ajpendo.1979.237.6.E509 CASPubMedWeb of Science®Google Scholar 19 Sonksen PH, Tompkins CV, Srivasta MC, and Nabarro JDN: A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med 45: 633–654, 1973. CASPubMedWeb of Science®Google Scholar 20 Pye S, Watarai T, Davies G, and Radziuk J: Comparison of the continuously calculated fractional splanchnic extraction of insulin with its fractional disappearance using a new double tracer technique. Metabolism 42: 145–153, 1993. 10.1016/0026-0495(93)90028-M CASPubMedWeb of Science®Google Scholar 21 Turner RC, Grayburn JA, Newman GB, and Nabarro JDN: Measurement of the insulin delivery rate in man. J Clin Endocrinol Metab 33: 279–286, 1971. 10.1210/jcem-33-2-279 CASPubMedWeb of Science®Google Scholar 22 Pilo A, Ferrannini E, and Navalesi R: Measurement of insulin delivery rate in man by deconvolution analysis. Am J Physiol 233: E500–E508, 1977. CASPubMedWeb of Science®Google Scholar 23 Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, and DeFronzo RA: Splanchnic and renal metabolism of insulin in human subjects. A dose response study. Am J Physiol 244: E517–E527, 1983. 10.1152/ajpendo.1983.244.6.E517 CASPubMedWeb of Science®Google Scholar 24 Thorsteinsson B, Fugleberg S, Feldt-Rasmussen B, and Binder C: Kinetic models for plasma disappearance of insulin in normal subjects. Acta Pharmacol Toxicol 57: 309–316, 1985. 10.1111/j.1600-0773.1985.tb00050.x CASPubMedWeb of Science®Google Scholar 25 Morishima T, Bradshaw C, and Radziuk J: Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs. Am J Physiol 248: E203–E208, 1985. CASPubMedWeb of Science®Google Scholar 26 Shapiro ET, Tillil H, Miller A, Frank BH, Galloway JA, Rubenstein AH, and Polonsky KS: Insulin secretion and clearance. Comparison after oral and intravenous glucose. Diabetes 36: 1365–1371, 1987. 10.2337/diab.36.12.1365 CASPubMedWeb of Science®Google Scholar 27 Tillil H, Shapiro ET, Rubenstein AH, Galloway JA, and Polonsky K: Reduction of insulin clearance during the hyperglycemic clamp: dose-response in normal humans. Diabetes 37: 1351–1357, 1988. 10.2337/diabetes.37.10.1351 CASPubMedWeb of Science®Google Scholar 28 Hovorka R, Powrie JK, Smith GD, Sonksen PH, Carson ER, and Jones RH: Five-compartment model of insulin kinetics and its use to investigate action of chloroquine in NIDDM. Am J Physiol 265: E162–E175, 1993. 10.1152/ajpendo.1993.265.1.E162 CASPubMedWeb of Science®Google Scholar 29 Field JB: Extraction of insulin by the liver. Annu Rev Med 24: 309–314, 1973. 10.1146/annurev.me.24.020173.001521 CASPubMedWeb of Science®Google Scholar 30 Ferrannini E, and Cobelli C: The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev 3: 365–397, 1987. 10.1002/dmr.5610030202 PubMedGoogle Scholar 31 Blackard WG, Ludeman C, and Stillman J: Role of hepatocyte plasma membrane in insulin degradation. Am J Physiol 248: E194–E202, 1985. CASPubMedWeb of Science®Google Scholar 32 Fleig WE, Hoss G, Nother-Fleig B, and Ditschuneit H: Insulin binding to cultured adult hepatocytes: effects of bacitracin and chloroquine on the nature of cell-associated radioactivity. Biochem J 237: 99–104, 1986. CASPubMedWeb of Science®Google Scholar 33 Caro JF, and Amatruda JM: Functional relationships between insulin binding, action, and degradation. J Biol Chem 255: 10052–10055, 1980. CASPubMedWeb of Science®Google Scholar 34 Caro JF, and Amatruda JM: Evidence for modulation of insulin action and degradation independently of insulin binding. Am J Physiol 240: E325–E332, 1981. CASPubMedWeb of Science®Google Scholar 35 Levy JR, and Olefsky JM: The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes. Endocrinology 121: 2075–2086, 1987. 10.1210/endo-121-6-2075 CASPubMedWeb of Science®Google Scholar 36 Tranberg KG, and Dencker H: Modeling of plasma disappearance of unlabeled insulin in man. Am J Physiol 235: E577–E585, 1978. 10.1152/ajpendo.1978.235.6.E577 CASPubMedWeb of Science®Google Scholar 37 Sodoyez JC, Sodoyez-Goffaux F, Goff NM, Zimmerman AE, and Arquilla ER: 127I- or carrier-free 125I-monoiodoinsulin. Preparation, physical, immunological, and biological properties, and susceptibility to "insulinases" degradation. J Biol Chem 250: 4268–4277, 1975. CASPubMedWeb of Science®Google Scholar 38 Waldhäusl WK, Gasic S, Bratusch-Marrain P, Korn A, and Nowotny P: Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. Am J Physiol 243: E476–E482, 1982. 10.1152/ajpendo.1982.243.6.E476 CASPubMedWeb of Science®Google Scholar 39 Tillil H, Shapiro ET, Miller A, Karrison T, Frank BH, Galloway JA, Rubenstein AH, and Polonsky K: Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol 254: E349–E357, 1988. CASPubMedWeb of Science®Google Scholar 40 Wirth A, Diehm C, Mayer H, Mori H, Vogel I, Bjorntorp P, and Schlierf G: Plasma C-peptide and insulin in trained and untrained subjects; J Appl Physiol 50: 71–77, 1981. PubMedWeb of Science®Google Scholar 41 Kirwan JP, Bourey RE, Kohrt WM, Staten MA, and Holloszy JO: Effects of treadmill exercise to exhaustion on the insulin response to hyperglycemia in untrained men. J Appl Physiol 70: 246–250, 1991. CASPubMedWeb of Science®Google Scholar 42 Duckworth WC, Gifford D, Kitabchi AE, Runyan D, and Solomon SS: Insulin binding and degradation by muscles from streptozotocin-diabetic rats. Diabetes 28: 746–750, 1979. 10.2337/diabetes.28.8.746 CASPubMedWeb of Science®Google Scholar 43 Rabkin R, Reaven GM, and Mondon CE: Insulin metabolism by liver, muscle, and kidneys from spontaneously diabetic rats. Am J Physiol 250: E530–537, 1986. CASPubMedWeb of Science®Google Scholar 44 Levy JR and Olefsky JM: The effect of insulin concentration on retroendocytosis in isolated rat adipocytes. Endocrinology 120: 450–456, 1987. 10.1210/endo-120-2-450 CASPubMedWeb of Science®Google Scholar 45 Jochen AL, Bernhanu P, and Olefsky J: Insulin internalization and degradation in adipocytes from normal and type II diabetic subjects. J Clin Endocrinol Metab 62: 268–274, 1986. 10.1210/jcem-62-2-268 CASPubMedWeb of Science®Google Scholar 46 Trischitta V, Gullo D, Squatrito S, Pezzino V, Goldfine ID, and Bigneri R: Insulin internalization into monocytes: studies in patients with type II diabetes mellitus. J Clin Endocrinol Metab 62: 522–528, 1986. 10.1210/jcem-62-3-522 CASPubMedWeb of Science®Google Scholar 47 Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, and Dohm LG: Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes. J Clin Invest 79: 1330–1337, 1987. 10.1172/JCI112958 CASPubMedWeb of Science®Google Scholar 48 Butterfield WJH, Garrett CJ, and Whichelow MJ: Peripheral hormone action: studies on the clearance and effect of 131I-iodoinsulin in the peripheral tissues of normal, acromegalic, and diabetic subjects. Clin Sci (Oxford) 24: 331–340, 1963. CASWeb of Science®Google Scholar 49 Rasio E, Whichelow MJ, Butterfield WJH, and Hicks BH: Insulin fixation and glucose uptake by forearm tissue in response to infusions of physiological amounts of insulin in nondiabetic subjects. Diabetologia 8: 244–250, 1972. 10.1007/BF01225567 CASPubMedWeb of Science®Google Scholar 50 Hammarsten J, Holm J, Björntorp P, and Schersten T: Glucose tolerance and fractional extraction of glucose and insulin in patients with peripheral arterial insufficiency. Effect of arterial reconstructive surgery. Metabolism 26: 883–891, 1977. 10.1016/0026-0495(77)90007-5 CASPubMedWeb of Science®Google Scholar 51 Polonsky KS, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moosa AR, Tager H and Rubenstein AH: Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest 72: 1114–1123, 1983. 10.1172/JCI111036 CASPubMedWeb of Science®Google Scholar 52 Polonsky KS, and Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33: 486–496, 1984. 10.2337/diab.33.5.486 CASPubMedWeb of Science®Google Scholar 53 Faber OK, Hagen C, Binder C, Marussen J, Naithami VK, Blix PM, Kuzuya H, Horwith DL, Rubenstein AH, and Rossing N: Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 62: 197–203, 1978. 10.1172/JCI109106 CASPubMedWeb of Science®Google Scholar 54 Malaisse WJ, and Scholler Y: Mathematical modelling of changes in circulating insulin and C-peptide concentrations. Acta Diabetol Lat 22: 127–137, 1985. 10.1007/BF02590786 CASPubMedWeb of Science®Google Scholar 55 Kowarski AR, Thompson CJ, Migeon J, and Blizzard RM: Determinations of the integrated plasma concentrations and true secretion rates of growth hormone. J Clin Endocrinol Metab 32: 356–360, 1971. 10.1210/jcem-32-3-356 CASPubMedWeb of Science®Google Scholar 56 Castillo MJ, Scheen AJ, Luyckx AS, and Lefèbvre PJ: Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter. Diabetologia 25: 120–122, 1983. 10.1007/BF00250899 CASPubMedWeb of Science®Google Scholar 57 Horwith DL, Starr JI, Mako ME, and Rubenstein AH: Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278–1283, 1975. 10.1172/JCI108047 PubMedWeb of Science®Google Scholar 58 Savage P, Flock EV, Mako M, Blix P, Rubenstein AH, and Bennett P: C-peptide and insulin secretion in Pima Indians and Caucasians; constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. J Clin Endocrinol Metab 48: 594–598, 1979. 10.1210/jcem-48-4-594 CASPubMedWeb of Science®Google Scholar 59 Johnston DG, Alberti KGMM, Faber OK, Binder C, and Wright R: Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet 1: 10–12, 1977. 10.1016/S0140-6736(77)91652-X CASPubMedWeb of Science®Google Scholar 60 Faber OK, Christensen K, Kehlet H, Madsbad S, and Binder C: Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53: 618–621, 1981. 10.1210/jcem-53-3-618 CASPubMedWeb of Science®Google Scholar 61 Rossell R, Gomis R, Casamitjana R, Segura R, Vilardell E, and Rivera F: Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab 56: 608–611, 1983. 10.1210/jcem-56-3-608 CASPubMedWeb of Science®Google Scholar 62 Meistas MT, Margolis S, and Kowarski AA: Hyperinsulinaemia of obesity is due to decreased clearance of insulin. Am J Physiol 245: E155–E159, 1983. 10.1152/ajpendo.1983.245.2.E155 CASPubMedWeb of Science®Google Scholar 63 Bonora E, Zavaroni I, Coscelli C, and Butturini U: Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 32: 438–446, 1983. 10.1016/0026-0495(83)90004-5 CASPubMedWeb of Science®Google Scholar 64 Sando H, Lee SV, Iwamoto T, Ikeuch M, and Kosaka: Isoproterenol stimulated C-peptide and insulin secretion in diabetic and non-obese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes. J Clin Endocrinol Metab 51: 1143–1149, 1980. 10.1210/jcem-51-5-1143 CASPubMedWeb of Science®Google Scholar 65 Madsbad S, Kehlet H, Hilsted J, and Troner B: Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes 32: 436–438, 1983. 10.2337/diab.32.5.436 CASPubMedWeb of Science®Google Scholar 66 Faber OK, Madsbad S, Kehlet H, and Binder C: Pancreatic beta-cell secretion during oral and intravenous glucose administration. Acta Med Scand 624 (Suppl): 61–64, 1979. CASPubMedGoogle Scholar 67 Hampton SM, Morgan LM, Tredger JA, Cramb R, and Marks S: Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion. Diabetes 35: 612–616, 1986. CASPubMedWeb of Science®Google Scholar 68 Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, and Creutzfeldt W: Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63: 492–498, 1986. 10.1210/jcem-63-2-492 CASPubMedWeb of Science®Google Scholar 69 Shuster LT, Go VLW, Rizza RA, O'Brien PC, and Service FJ: Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes 37: 200–203, 1988. 10.2337/diab.37.2.200 CASPubMedWeb of Science®Google Scholar 70 Creutzfeldt W: The changing concept of the enteroinsular axis. Front Horm Res 16: 1–14, 1987. Web of Science®Google Scholar 71 Dupré J, Behme MT, Hramiak IM, and Longo CJ: Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients. Metabolism 42: 921–927, 1993. 10.1016/0026-0495(93)90001-5 PubMedWeb of Science®Google Scholar 72 Jackson RA, Blix PM, Matthews JA, Hamling JB, Din BM, Brown DC, Belin J, Rubenstein AH, and Nabarro JDN: Influence of ageing on glucose homeostasis. J Clin Endocrinol Metab 55: 840–848, 1982. 10.1210/jcem-55-5-840 CASPubMedWeb of Science®Google Scholar 73 Proudler AJ, Felton CV, and Stevenson JC: Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sci 83: 489–494, 1992. 10.1042/cs0830489 CASPubMedWeb of Science®Google Scholar 74 Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, and Melis GB: Effects of low dose of transdermal 17B-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 74: 1396–1400, 1992. 10.1210/jc.74.6.1396 CASPubMedWeb of Science®Google Scholar 75 Greco AV, Crucitti F, Ghirlanda G, Manna R, Altomente L, Rebuzzi AG, and Bertoli A: Insulin and glucagon concentrations in portal and peripheral vein in patients with hepatic cirrhosis. Diabetologia 17: 23–28, 1979. 10.1007/BF01222973 CASPubMedWeb of Science®Google Scholar 76 Johnston DG, Alberti KGMM, Wright R, Smith-Laing G, Stewart AM, Sherlock S, Faber O, and Binder C: C-peptide and insulin in liver disease. Diabetes 27 (Suppl 1): 201–206, 1978. 10.2337/diab.27.1.S201 CASPubMedWeb of Science®Google Scholar 77 Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, and Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81: 435–441, 1988. 10.1172/JCI113338 CASPubMedWeb of Science®Google Scholar 78 Arquilla ER, Ooms H, and Mercola K: Immunological and biological properties of iodoinsulin labeled with one or less atoms of iodine per molecule. J Clin Invest 47: 474–483, 1968. 10.1172/JCI105744 CASPubMedWeb of Science®Google Scholar 79 Hamlin JL, and Arquilla ER: Preparation, purification and characterization of a biologically active derivative substituted predominantly on tyrosine A14. J Biol Chem 249: 21–32, 1974. CASPubMedWeb of Science®Google Scholar 80 Citti L, Ferrannini E, Battini L, and Navalesi R: Radioimmunoassay of labeled and unlabeled insulin mixtures. J Nucl Biol Med 20: 75–78, 1976. CASPubMedWeb of Science®Google Scholar 81 Freychet P, Roth J, and Neville DM: Monoiodo-insulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun 43: 400–408, 1971. 10.1016/0006-291X(71)90767-4 CASPubMedWeb of Science®Google Scholar 82 Gliemann J, Gammeltoft S, and Vinten J: Time-course of insulin-receptor binding and insulin-induced lipogenesis in isolated rat fat cells. J Biol Chem 250: 3368–3374, 1975. CASPubMedWeb of Science®Google Scholar 83 Le Cam A, Freychet P, and Lenoir P: Degradation of insulin by isolated rat liver cells. Diabetes 24: 566–573, 1975. CASPubMedWeb of Science®Google Scholar 84 Halban PA, and Offord RE: The preparation of semisynthetic tritiated insulin with a specific radioactivity of up to 20 curies per millimole. Biochem J 151: 219–225, 1975. 10.1042/bj1510219 CASPubMedWeb of Science®Google Scholar 85 Stern MP, Farquar JW, Silbers A, and Reaven GM: Insulin delivery rate into plasma in normal and diabetic subjects. J Clin Invest 47: 1947–1957, 1968. 10.1172/JCI105884 CASPubMedWeb of Science®Google Scholar 86 Ferrannini E, and Pilo A: Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest 64: 243–254, 1979. 10.1172/JCI109445 CASPubMedWeb of Science®Google Scholar 87 Terris S, and Steiner DF: Binding and degradation of insulin-I125 by rat hepatocytes. J Biol Chem 250: 8389–8398, 1975. CASPubMedWeb of Science®Google Scholar 88 Rubenstein AH, and Spitz I: Role of the kidney in insulin metabolism and excretion. Diabetes 17: 161–169, 1968. 10.2337/diab.17.3.161 CASPubMedWeb of Science®Google Scholar 89 Ooms HA, Arnould Y, Rosa U, Pennisi GF, and Franckson JRM: Total metabolic clearance of crystalline insulin and radioiodine substituted insulin. Pathol Biol (Paris) 16: 241–245, 1968. CASPubMedWeb of Science®Google Scholar 90 Ellis MJ, Jones RH, Thomas JH, Geizer R, Teetz V, and Sonksen PH: Bl-3,5-diiodotyrosine insulin: a valid tracer for insulin. Diabetologia 13: 257–261, 1977. 10.1007/BF01219709 CASPubMedWeb of Science®Google Scholar 91 Cockram CS, Bahrami S, Bordujerdi MA, Jones RH, and Brandenburg D: B1-monoiodoinsulin: a comparison with other tracers. Diabetologia 13: 257–261, 1977. PubMedWeb of Science®Google Scholar 92 Genuth SM: Metabolic clearance of insulin in man. Diabetes 1: 1003–1012, 1972. 10.2337/diab.21.10.1003 Google Scholar 93 Polonsky K, Given BD, Pugh J, Licinio-Paixao J, Thompson JE, Karrison T, and Rubenstein AH: Calculation of the systemic delivery rate of insulin in normal man. J Clin Endocrinol Metab 63. 113–118, 1986. 10.1210/jcem-63-1-113 CASPubMedWeb of Science®Google Scholar 94 Kollind M, Moberg E, Liu D, Lins PE, and Adamson U: Insulin clearance during hypoglycemia in patients with insulin-dependent diabetes mellitus. Horm Metab Res 23: 333–335, 1991. 10.1055/s-2007-1003690 CASPubMedWeb of Science®Google Scholar 95 Ipp E, Sinai Y, Bar-oz B, Nesher R, and Cerasi E: Somatostatin impairs clearance of exogenous insulin in humans. Diabetes 36: 673–677, 1987. 10.2337/diabetes.36.5.673 CASPubMedWeb of Science®Google Scholar 96 Kitabchi AE: Proinsulin and C-peptide. A review. Metabolism 26: 547–587, 1977. 10.1016/0026-0495(77)90099-3 CASPubMedWeb of Science®Google Scholar 97 Van Cauter E, Mestrez F, Sturis J, and Polonsky K: Estimation of insulin secretion rates from C-peptide levels. Diabetes 41: 368–377, 1992. 10.2337/diabetes.41.3.368 CASPubMedWeb of Science®Google Scholar 98 Pilo A, Navalesi R, and Ferrannini E: Insulin kinetics after portal and peripheral injection of 125I-insulin. I. Data analysis and modeling. Am J Physiol 230: 1626–1629, 1976. CASPubMedWeb of Science®Google Scholar 99 Navalesi R, Pilo A, Lenzi S, and Donato L: Insulin metabolism in chronic uremia and in the anephric state: effect of the dialytic treatment. J Clin Endocrinol Metab 40: 70–85, 1975. 10.1210/jcem-40-1-70 CASPubMedWeb of Science®Google Scholar 100 Ferrannini E, Pilo A, Navalesi R, and Citti L: Insulin kinetics and glucose-induced insulin delivery in chronically dialyzed subjects: acute effects of dialysis. J Clin Endocrinol Metab 49: 15–22, 1979. 10.1210/jcem-49-1-15 CASPubMedWeb of Science®Google Scholar 101 Tait JF: The use of isotopic steroids for the measurement of production rates in vivo. J Clin Endocrinol Metab 23: 1285–1297, 1963. 10.1210/jcem-23-12-1285 CASPubMedWeb of Science®Google Scholar 102 Polonsky KS, Licinio-Paixao J, Given BD, Puch W, Rue P, Galloway J, Karrison T, and Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77: 98–105, 1986. 10.1172/JCI112308 CASPubMedWeb of Science®Google Scholar 103 Letiexhe MR, Scheen AJ, Gérard PL, Bastens B, Pirotte J, Belaiche J, and Lefèbvre PJ: Insulin secretion, clearance and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 77: 1263–1268, 1993. 10.1210/jc.77.5.1263 CASPubMedWeb of Science®Google Scholar 104 Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, and Lefèbvre PJ: Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obesity 18: 295–300, 1994. PubMedWeb of Science®Google Scholar 105 Bergman RN, Steil GM, Bradley DC, and Watanabe RM: Modeling of insulin action in vivo. Annu Rev Physiol 54: 861–883, 1992. 10.1146/annurev.ph.54.030192.004241 CASPubMedWeb of Science®Google Scholar 106 Goldstein BJ, and Livingston JN: Insulin degradation by insulin target cells. Metabolism 30: 825–835, 1981. 10.1016/0026-0495(81)90030-5 CASPubMedWeb of Science®Google Scholar 107 Gray RS, Scarlett JA, Griffin J, Olefsky JM, and Kolterman OG: In vivo deactivation of peripheral, hepatic, and pancreatic insulin action in man. Diabetes 31: 929–936, 1982. 10.2337/diabetes.31.10.929 CASPubMedWeb of Science®Google Scholar 108 Jansson PAE, Fowelin JP, Von Schenck HP, Smith UP, and Lönnroth PN: Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Diabetes 42: 1469–1473, 1993. CASPubMedWeb of Science®Google Scholar 109 Carson ER, Cobelli C, and Finkelstein L: Mathematical Modeling of Metabolic and Endocrine Systems. Model Formulation, Identification and Validation. John Wiley, New York, 1983. Google Scholar 110 McGuire EA, Tobin JD, Berman M, and Andres R: Kinetics of native insulin in diabetic, obese and aged man. Diabetes 28: 110–120, 1979. CASPubMedWeb of Science®Google Scholar 111 Navalesi R, Benzi L, Paci A, Pilo A, Giam
Referência(s)